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Lichens represent a promising source of antimicrobial, cytotoxic and antioxidant agents. Their great
pharmacological potential lies in the fact that they represent specific symbiotic organisms and thus
possess natural roles allowing them to be highly adaptable to different environmental conditions.
On the other hand, stated biological activities of lichens with prospective medicinal significance may
be connected to their long-term use in the traditional treatment of various ailments. Genus Usnea
from the Parmeliaceae family is certainly one of the best studied in terms of chemical composition
and biological properties of its extracts and/or isolated compounds. In the first part of the study, a
detailed review of the literature has been performed yielding a detailed report on the investigations
of biological activities of the lichens belonging to this genus. In the second part of the study, the
chemical composition of the lichens from the genus was described and, additionally, a survey of the
biological properties of the most representative secondary metabolites in these lichens has been re-
ported. It could be concluded that the extracts and/or isolated compounds from the lichens belonging
to the genus Usnea may be considered a valuable source of prospective drug candidates with potential
clinical relevance.
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1. INTRODUCTION
Lichens are considered stable, ecologically obligate symbiotic
associations between fungi (mycobiont) and one or more pho-
tosynthetic partners: eukaryotic alga and/or cyanobacteria
(photobiont) or in some cases non-photosynthetic bacteria
(Molnár and Farkas, 2010; Shrestha and St. Clair, 2013). Con-
sidering that approximately 21% of all fungi are able to act as
mycobiont in lichen, it is not surprising that they represent the
largest mutualistic group among fungi. Therefore, since 1983,
the name of the lichen refers to its mycobiont, that is, they
belong to the kingdom of Fungi according to the biological
classification (Shrestha and St. Clair, 2013).
Due to the growing development of new methods of chemical
analysis enabling the discovery of new substances and their
structures, biochemical analysis of lichens went through “ex-
ponential” development in past decades. In the past decades,
approximately 1050 secondary metabolites of lichens have
been identified, including the substances found in the intact
thalli of lichen, as well as compounds identified in the cul-
ture of lichens (Shrestha and St. Clair, 2013). Unlike primary
metabolites that have a structural function and are synthesized
independently by both symbionts, secondary metabolites are
produced exclusively by mycobionts, after which they are
transported outside the hyphae and are deposited in different
parts of the thallus, most often in the upper cortex or in the
medullary layer, as extracellular small crystals on the outer sur-
faces of the hyphae. In accordance to their function, secondary
metabolites of lichens are limited to certain parts of the thal-
lus, while the patterns of their distribution are taxons-specific,
which is widely used in the lichen systematics (Molnár and
Farkas, 2010; Shrestha and St. Clair, 2013).
Secondary metabolites of the lichens include chemically dis-
tinct aliphatic and aromatic compounds of relatively small
molecular weights, most of which are from the acetyl-
polymalonyl biosynthetic pathway, while a smaller num-
ber originate from mevalonic acid and shikimic acid biosyn-
thetic pathway (Figure 1). Although derived exclusively from
the mycobiont, the metabolic interaction between mycobiont
and photobiont in lichens is necessary for the production of
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secondary metabolites, which is associated with their large
metabolic diversity. Therefore, only a very small number of
these compounds (50-60) can be found in other organisms,
such as non-lichenized fungi or higher plants (Molnár and
Farkas, 2010).
In recent years, the biological activities of lichens and their
secondary metabolites with potential medicinal significance
have been intensively investigated, which is, on the one
hand, related to their natural roles allowing them to be
highly adaptable to different environmental conditions (de-
fense against UV radiation and protection against predators
and pathogenic microorganisms), and on the other to their
traditional use in the treatment of various diseases (bronchi-
tis, asthma, blood and heart diseases, leprosy, scabies, stom-
ach disorders, etc.) (Gómez-Serranillos et al., 2014; Shrestha
and St. Clair, 2013). These studies implied a large pharmaco-
logical potential of lichens and/or their secondary metabo-
lites as a promising source of potential medicines with anti-
cancer, antimicrobial, anti-inflammatory and antioxidant ac-
tivity (Gómez-Serranillos et al., 2014; White et al., 2014).
In this regard, the genus Usnea of the Parmeliaceae family
has been extensively studied. It encompasses around 300
species widely distributed from polar zones to tropical regions.
Diagnostic characteristics of the genus include shrubby thallus
with pale, yellowish-green branches with radial symmetry, a
cartilaginous central and the presence of usnic acid in the
cortex (Clerc, 1998; Gómez-Serranillos et al., 2014; Ohmura,
2012). Due to their specific appearance, members of this genus
are also referred to as ‘beard-like’ lichens (Clerc, 1998; Gómez-
Serranillos et al., 2014). In this paper chemical composition
and biological activities of the species of the genus Usnea
as well as the biological activities of secondary metabolites
identified in the species of this genus will be presented (Table
1).
2. BIOLOGICAL ACTIVITIES OF THE SPECIES BE-
LONGING TO THE GENUS USNEA
2.1. Antimicrobial activity
As seen in Table 1, one of the most studied activities of the
species belonging to the genus Usnea is antimicrobial activity
(antibacterial, antimycotic, antiprotozoal and antiviral). Gen-
erally, it was observed that all species of Parmeliaceae family
had a stronger antimicrobial effect compared to the lichens-
members of other families, and also that the extracts prepared
with organic solvents were more active than the ones pre-
pared using water. This finding is probably connected to poor
solubility of lichen secondary metabolites in water (Gómez-
Serranillos et al., 2014). Recent study investigating 24 lichens
belonging to 6 different families indicated methanol extract
of Usnea sp. to possess antimicrobial activity against Gram-
positive (G(+)) bacteria, while there were no effects against
Gram-negative (G(-)) species and also against pathogenic fun-
gus - Candida albicans (Paudel et al., 2012). On the other hand,
in the research of Rukayadi et al. (2008) screening 23 medicinal
plants/lichens from Thailand against six pathogenic Candida
species, U. siamensis was active against Candida guilliermondii.
A study of Cansaran et al. (2006) involved 6 members of the
genus Usnea (U. florida, U. barbata, U. longissima, U. rigida, U.
hirta and U. subflorida) against various G(+) and G(-) bacte-
ria. U. subflorida showed the strongest antimicrobial activity,
which was correlated with the highest content of usnic acid in
this species. On the other hand, antimicrobial activity was ob-
served in other studies for two out of six investigated lichens
(U. barbata and U. florida). Namely, antibacterial, antimycotic
and antiprotozoal activity was confirmed for dichloromethane
and methanol extract of U. florida (Schmeda-Hirschmann et al.,
2008). Also, comparative analysis of acetone, methanol and
aqueous extract of U. barbata against 10 bacterial and 5 fungal
strains implied the strongest activity against G(+) bacterial
species i.e. the strongest antimicrobial effect of the acetone
extract (Madamombe and Afolayan, 2003). These findings
were confirmed in the recent study of Rankovic´ et al. (2012),
which detected stronger antimicrobial activity of the acetone
extract of U. barbata compared to the acetone extract of Toninia
candida against 5 bacteria and 5 fungi. Similar results were
reported in the study of Weckesser et al. (2007) that screened
9 lichen extracts and isolated compounds against bacterial
and fungal species with dermatological relevance, singling
out an extract of U. barbata prepared using supercritical CO2
as the most active one, especially against and Malassezia furfur.
Similarly, Zugic et al. (2015) reported supercritical CO2 extract
of U. barbata to have the strongest antimicrobial effect against
G(+) bacteria compared to the extracts of this lichen prepared
using conventional techniques. Relatively strong activity of
U. ghattensis was observed in a study that investigated antimi-
crobial activity of this lichen against G(+) and G(-) human
pathogenic bacterial species, whereby methanol extract was
the only extract active against Streptococcus faecalis, ethanolic
extract was more effective than acetone and methanol extract
against Bacillus cereus and Pseudomonas aeruginosa, while ace-
tone and methanol extract showed similar activity against
Staphylococcus aureus (Srivastava et al., 2013). These findings
are in line with the results of Behera et al. (2005a) which also
demonstrated antimicrobial activity of acetone and methanol
extract of U. ghattensis against S. aureus, and also three Bacillus
species. When it comes to antiviral activity, in a study that in-
volved 18 medicinal plants and lichens used as folk medicines
against infective diseases, significant antiviral activity was ex-
hibited for the Soxhlet extract of U. complanata against Herpes
simplex virus (HSV-1) in a concentration that was non-toxic to
Vero cells (African green monkey kidney cell) (Vijayan et al.,
2004).
2.2. Cytotoxic and antitumor activity
Since the early studies screening secondary metabolites of
lichens as potential anticancer agents, the activity of a vast
number of lichen crude extracts and/or isolated compounds
has been investigated against various cell lines suggesting
their promising antitumor, antimutagenic and cytotoxic ef-
fects (Gómez-Serranillos et al., 2014). One of the first studies
that involved acetone extracts of 29 tissue culture and thal-
lus extracts of lichens implied the extract of U. longissima to
possess the strongest inhibitory effect against Epstein Barr
virus-induced tumor (Yamamoto et al., 1995). Cytotoxic activ-
ity of U. fasciata was demonstrated against sarcoma 180 and
Ehrlich tumor cells; stated effect was moderate to strong de-
pending on the fraction isolated from the lichen (Periera et al.,
1994). Recent research (Rankovic´ et al., 2012) included inves-
tigation of cytotoxic activity of acetone extracts of U. barbata
and T. candida against FemX (human melanoma) and LS174
(human colon carcinoma) cell lines. Obtained IC50 values for
both tested cell lines were lower for the extract of U. barbata
compared to T. candida, while further analysis of the mecha-
nism of cytotoxic action implied a prominent ability of this
extract to induce apoptosis in tested cells. Similar results were
reported for a supercritical CO2 extract of this lichen against
B16 mouse melanoma and C6 rat glioma. Namely, supercriti-
cal CO2 extract of U. barbata revealed stronger cytotoxic effect
against tested tumor cells compared to conventional extracts
of this lichen and also pure usnic acid. Suggested mechanisms
of cytotoxic effect for both supercritical CO2 extract of U. bar-
bata and usnic acid were the induction of apoptosis and/or
autophagy in B16 and C6 cells, indicating higher cytotoxic-
ity of the extract to be related to the higher degree of ROS












Table 1. Chemical composition and biological activities of the species belonging to Usnea genus
Species Chemical composition Reference Biological activity Reference
Usnea articulata (L.) Hoffm.
Usnic acid, barbatic acid, atranorin,
methyl-β-orcinolcarboxylate and other β-
orcinol derivatives, ergosterol peroxide,
fumarprotocetraric acid, protocetraric acid,
stictic acid, norstictic acid, peristictic acid,
criptostictic acid, menegazziaic acid,
constictic acid, 3-O-methyl-consalazinic
acid
Lohézic-Le Dévéhat et al.
(2007) Antigenotoxic, antioxidant Ceker et al. (2015)
Usnea barbata (L.) Mott.
Usnic acid, norstictic acid, atranorin,
chloroatranorin, barbatolic acid, lobaric
acid, salazinic acid
List and Hörhammer (1979);
Rankovic´ et al. (2012)
Anti-inflammatory, UVB
protective effects Engel et al. (2007)
Antimicrobial (antibacterial,
antimycotic)
Cansaran et al. (2006);
Madamombe and Afolayan
(2003); Rankovic´ et al. (2012);
Weckesser et al. (2007)
Antimicrobial (antiviral) Vijayan et al. (2004)
Antioxidative Rankovic´ et al. (2012)
Cytotoxic Rankovic´ et al. (2012)
Usnea complanata (Müll.Arg.)
Motyka
Usnic acid, psoromic acid, salazinic acid,
norstictic acid, constictic acid, galbinic acid
Behera et al. (2012);
Swinscow and Krog (1979)
Antioxidative,
cardioprotective Behera et al. (2012)
Usnea fasciata Torrey Usnic acid, isolichenin, raffinose Periera et al. (1994) Cytotoxic Periera et al. (1994)
Usnea fillipendula Stirton Usnic acid, salazinic acid, thamnolic acid List and Hörhammer (1979) Antigenotoxic, antioxidative Ceker et al. (2015)
Usnea florida (L.) Weber ex Wigg.
Usnic acid, lecanoric acid, thamnolic acid,
diffractaic acid, squamatic acid, salazinic
acid, constictic acid, norstictic acid,
psoromic acid, protocetraric acid,
fumarprotocetraric acid, conpsoromic acid,
caperatic acid, Evans’s substance, lobaric
acid
Fiscus (1972); List and
Hörhammer (1979) Antimicrobial (antibacterial)
Cansaran et al. (2006);
Schmeda-Hirschmann et al.
(2008)
Antioxidative Odabasoglu et al. (2004)
Usnea ghattensis G. Awasthi Usnic acid, norstictic acid Verma et al. (2008) Antimicrobial (antibacterial) Behera et al. (2005a);Srivastava et al. (2013)
Antioxidative Behera et al. (2006; 2005a);Verma et al. (2008)












Continued from previous page
Species Chemical composition Reference Biological activity Reference
Usnea longissima Ach.
Usnic acid, barbatic acid, diffractaic acid,
glutinol, longissiminone A longissiminone
B, salazinic acid, protocetraric acid, evernic
acid, 4-O-demethyl-barbatic acid
Cansaran et al. (2006);
Choudhary et al. (2005); Jin
et al. (2008); List and
Hörhammer (1979);
Nishitoba et al. (1987);
Odabasoglu et al. (2005;




Ag˘ar et al. (2011); Kim and
Cho (2007); Odabasoglu et al.
(2004)
Antigenotoxic Ag˘ar et al. (2011)
Antiulcer Halici et al. (2005)
Antitumour Yamamoto et al. (1995)
Enzyme-inhibitory Kim and Cho (2007)
Antiplatelet Lee and Kim (2005)
Usnea siamenis Vain. Usnic acid, stictic acid, constictic acid,norstictic acid Swinscow and Krog (1979) Antimicrobial (antimycotic) Rukayadi et al. (2008)
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In addition, extracts of U. filipendula and U. articulata revealed
the ability to protect against aflatoxin B1 (AFB1)-induced geno-
toxic and oxidative damage, whereby it was concluded that
antigenotoxic effects of these lichens may be related to their an-
tioxidative potential (Ceker et al., 2015). Similar antigenotoxic
effects were reported for methanol extract od U. longissima
(Ag˘ar et al., 2011).
2.3. Antioxidative activity
Taking into consideration the polyphenolic nature of the main
secondary metabolites of lichens, it would be logical to as-
sume that these symbiotic organisms possess antioxidative
properties. Indeed, several studies conducted with the aim to
investigate this activity revealed promising results. Generally,
antioxidative activity was assessed using in vitro tests, such
as DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging
activity (DPPH assay), nitric oxide (NO) radical scavenging
activity, superoxide anion scavenging (SAS) assay, reduction
power and lipid peroxidation inhibition (LPO) assay, whereby
methanol was used as the most appropriate solvent for the
extraction of bioactive compounds with antioxidative activity
from lichens (Gómez-Serranillos et al., 2014). When it comes
to the genus Usnea, it was shown that methanol extracts of
U. articulata and U. filipendula have a protective role against
AFB1 in human lymphocytes via regulation of enzyme activ-
ity (Ceker et al., 2015). In another study, several extracts of
U. complanata revealed free radical scavenging activity (DPPH
and NO) and LPO inhibition (Behera et al., 2012). In addition,
various extracts of U. ghattensis demonstrated good antiox-
idant potential similar to the referent antioxidants (Behera
et al., 2006; 2005a;b; Verma et al., 2008). Also, methanol extract
of U. longissima exerted strong antioxidative capacity in vitro
(Ag˘ar et al., 2011; Kim and Cho, 2007), while in an in vivo
study aqueous extract of this lichen was able to activate super-
oxide dismutase (SOD) and glutathione S-transferase (GST)
reduced by indomethacin (Halici et al., 2005). In the study of
Odabasoglu et al. (2004) this lichen revealed better antioxidant
activity and higher content of total phenols compared to U.
longissima. Antioxidant activity was also observed for the two
members of the genus Usnea found in Antarctic (U. antarctica
and U. aurantiacoatra) (Luo et al., 2009). In the recent study of
Rankovic´ et al. (2012) antioxidative activity of acetone extract
of U. barbata was confirmed using three in vitro assays. Stated
activity, which was in good correlation with total phenolic
content, was, however, weaker than the one demonstrated for
acetone extract of T. candida. A good correlation of antioxi-
dant capacity and total phenolic/usnic acid content in several
extracts of U. barbata was also confirmed by Zugic et al. (2016).
2.4. Other activities
Beside antimicrobial, cytotoxic and antioxidative activity,
some of the members of the genus Usnea were shown to pos-
sess additional biological activities. In a study of (Engel et al.,
2007) that investigated anti-inflammatory activity of a super-
critical CO2 extract of U. barbata, inhibition of prostaglandin
(PGE2) and cyclooxygenase (COX-2) production in the HaCaT
keratinocytes exposed to ultraviolet-B radiation was demon-
strated. Beside the enzymes that are mediators of inflamma-
tion, some of the lichens belonging to the genus Usnea revealed
the ability to inhibit other enzymes. For instance, Kim and Cho
(2007) observed an inhibitory effect of the methanol extract of
U. longissima to melanogenesis via tyrosinase inhibition thus
lowering the level of melanin in human melanoma cells. In ad-
dition, water extract of the same lichen revealed a promising
gastroprotective effect mediated by an antioxidative mech-
anism (Halici et al., 2005). Moreover, Lee and Kim (2005)
reported cardioprotective effects of the methanol extract of
the same lichen, which also exerted antiplatelet activity. Car-
dioprotective activity was also described for U. complanata
(Behera et al., 2012), while U. ghattensis was shown to possess
hepatoprotective activity mediated by antioxidative mecha-
nisms against ethanol-induced toxicity in mice (Verma et al.,
2008).
3. THE CHEMICAL COMPOSITION OF THE LICHENS
BELONGING TO THE GENUS USNEA AND THEIR
BIOLOGICAL ACTIVITIES
3.1. The chemical composition of the lichens belonging to
the genus Usnea
Table 1 reveals the chemical composition of the lichens be-
longing to the genus Usnea, for which some of the biological
activities described in the first part of this paper have been
shown. In the detailed survey of the available literature, 35
metabolites were found in stated species of the genus Usnea
(Table 1). Thereof, usnic acid was identified in all of the de-
scribed species, which is not surprising given the fact that this
compound is characteristic for the species that have a yellow-
green upper cortex, including, in addition to the genus Usnea,
other genera of the Parmeliaceae family, such as Alectoria, Ev-
ernia, and Flavoparmelia (Gómez-Serranillos et al., 2014). In
addition to usnic acid, following 13 compounds were identi-
fied in more than one species of the genus Usnea: salazinic acid
(in 6 species), norstictic acid (in 4 species), barbatic, constictic,
protocetraric, stictic and thamnolic acid (each in 3 species),
atranorin, diffractaic, fumarprotocetraric, galbinic, lobaric and
psoromic acid (each in 2 species), while other metabolites
were found in only one species (Table 1). For some of these
metabolites, different biological activities were described in
the literature, which will be presented in the following section.
3.2. Biological activities of the secondary metabolites of the
lichens belonging to the genus Usnea
3.2.1. Usnic acid
Usnic acid (Figure 2) is one of the most prevalent and best
studied secondary metabolites of the lichens. It is naturally
occurring dibenzofuran derivative, isolated not only from
the representatives of the genus Usnea (Behera et al., 2012;
Brandão et al., 2013; Cansaran et al., 2006; Gupta et al., 2012;
Honda et al., 2010; Odabasoglu et al., 2006; Rankovic´ et al.,
2012; Safak et al., 2009; Schmeda-Hirschmann et al., 2008; Sul-
tana and Afolayan, 2011; Yamamoto et al., 1995), but also
from some other genera such as Parmelia (Kumar KC and
Müller, 1999a;b; Manojlovic´ et al., 2012; Rankovic´ et al., 2008),
Protousnea (Fournet et al., 1997; Schmeda-Hirschmann et al.,
2008), Alectoria (Einarsdóttir et al., 2010; Gollapudi et al., 1994),
Xantoparmelia (Amo de Paz et al., 2010; Ingólfsdóttir et al.,
1998), Lethariella (Toledo Marante et al., 2003), Cladonia (Be-
hera et al., 2012; Bessadottir et al., 2012; Lohézic-Le Dévéhat
et al., 2007; Rankovic´ et al., 2012; Santos et al., 2004; Singh
et al., 2013) and others. Usnic acid has been recognized as
the carrier of various biological activities, such as antimicro-
bial, antioxidant, antitumor, neuroprotective, gastroprotec-
tive, cardioprotective, cytoprotective, immunostimulatory and
anti-inflammatory. Recently, the wound healing properties
for this compound were confirmed, as well (Burlando et al.,
2009). Antimicrobial activity of usnic acid was investigated
in many scientific papers and most of them described screen-
ing of this dibenzofuran derivative against various bacteria,
fungi, and parasites. Its antibacterial activity has been docu-
mented for many G(+) bacteria (Gollapudi et al., 1994; Ivanova
et al., 2010; Manojlovic´ et al., 2012; Rankovic´ et al., 2012; 2008;
Schmeda-Hirschmann et al., 2008; Sultana and Afolayan, 2011;
Weckesser et al., 2007; Zugic et al., 2015). In a recently pub-
lished study dealing with the evaluation of usnic acid antibac-
terial activity against methicillin-resistant S. aureus (MRSA), it
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Fig. 1. Biosynthetic pathways of lichens metabolites (taken from Rankovic´ and Kosanic´ (2015))
Fig. 2. Chemical structure of (+) and (-) enantiomer of usnic acid
was found that the mechanism of antistaphylococcal activity
was based on its capability to trigger the bacterial cell mem-
brane destruction (Gupta et al., 2012). When it comes to G(-)
bacteria and fungi, in the up-to-now available literature, the
data are controversial. Namely, some studies pointed to the
absence of antibacterial activity of usnic acid against G(-) bac-
teria (Gollapudi et al., 1994; Weckesser et al., 2007; Zugic et al.,
2015) and fungi (Ivanova et al., 2010; Schmeda-Hirschmann
et al., 2008; Weckesser et al., 2007). However, in several papers,
it was demonstrated that usnic acid exhibited very strong an-
timicrobial properties against all tested bacteria (including
G(+) and G(-)) and fungi, with antibacterial activity being
stronger than antimycotic (Manojlovic´ et al., 2012; Rankovic´
et al., 2012; 2008). In addition, antiprotozoal activity against
three Leishmania species was evaluated in vitro as well as in
vivo, in experimentally induced skin leishmaniasis (Fournet
et al., 1997; Schmeda-Hirschmann et al., 2008). Among all
the secondary metabolites of the lichens, the best-studied sub-
stance for its anticancer effects is definitely usnic acid. Usnic
acid exhibited antitumor activity against tumors caused by
Epstein Barr virus (Yamamoto et al., 1995). The significant
cytotoxic activity was observed in investigations performed
on human keratinocytes (Burlando et al., 2009; Kumar KC
and Müller, 1999b), malignant mesothelioma cells (MM98),
vulvar carcinoma cells (A431 vulvar) (Burlando et al., 2009),
mouse fibroblasts cells (L-929), human leukaemia cells (K-562,
U937, HL-60, Jurkat) (Bacˇkorová et al., 2011; Ivanova et al.,
2010; Toledo Marante et al., 2003) human cervix carcinoma
Fig. 3. Chemical structure of metabolites of the Usnea lichens with
depside structure: atranorin (A), diffractaic acid (B), barbatic acid
(C), chloroatranorin (D) evernic acid (E) and lecanoric acid (F)
cells (HeLa) (Brisdelli et al., 2013; Ivanova et al., 2010), human
breast adenocarcinoma cells (MCF-7 and SK-BR-3) Bacˇkorová
et al. (2011); Brisdelli et al. (2013), melanoma cells (B16, FemX
and UACC-62) (Brandão et al., 2013; Manojlovic´ et al., 2012;
Rankovic´ et al., 2012; Zugic et al., 2016), human colon carci-
noma (LS174, HCT-116, HT-29) (Bacˇkorová et al., 2011; Bris-
delli et al., 2013; Manojlovic´ et al., 2012; Rankovic´ et al., 2012)
and glioma cells (C6) (Zugic et al., 2016).
Taking into account previously performed studies, the pro-
posed mechanisms of usnic acid cytotoxicity might be based
on:
(a) antimitotic activity (Cardarelli et al., 1997), causing the
inhibition of RNA transcription (Campanella et al., 2002)
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Fig. 4. Chemical structure of metabolites of the Usnea lichens with depsidone structure: salazinic acid (A), stictic acid (B), fumaroprotocetric
acid (C), lobaric acid (D), norstistic acid (E), protocetraric acid (F), psoromic acid (G), galbinic acid (H) and menegazziaic acid (I)
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(b) disruption of internal mitochondrial membrane potential
(Einarsdóttir et al., 2010; Han et al., 2004)
(c) induction of apoptosis (Bacˇkorová et al., 2011; Bézivin
et al., 2004; Rankovic´ et al., 2012; Zugic et al., 2016) and
autophagy (Bessadottir et al., 2012; Zugic et al., 2016)
Usnic acid specific heterocyclic structure consisting of conju-
gated dienes and polar OH groups indicates the possible redox
potential of this molecule or the ability of its interaction with
reactive species involved in oxidative stress. Antioxidant po-
tential of usnic acid, as well as it’s biological activities based on
antioxidative properties, have recently been described in the
review of White et al. (2014). In this respect, the antioxidant
activity of this lichen metabolite was detected in numerous
in vitro assays (Amo de Paz et al., 2010; Behera et al., 2012;
Rankovic´ et al., 2012; Singh et al., 2013). However, the results
of various biological tests suggested that usnic acid could
act both as a prooxidant or antioxidant in different types of
cells and tissues, pointing the further research necessity re-
garding the mechanisms of its activity. Its redox potential
might be fully understood only if the further investigations
were performed taking into consideration the usnic acid possi-
ble effects on modulation of antioxidant enzyme activity and
detoxification cell systems (Kohlhardt-Floehr et al., 2010; Polat
et al., 2016). In contrast, or better to say in line with the above-
mentioned, some papers reported the absence of antioxidant
activity, as usnic acid did not show the ability to "capture"
the free radicals generated in DPPH test (Lohézic-Le Dévéhat
et al., 2007; Thadhani et al., 2011; Zugic et al., 2016), what had
been explained by the lack of a labile hydrogen atom in the
structure of this compound.
When it comes to the biological properties of usnic acid
based on its antioxidant potential, this compound exhibited
gastroprotective effects against gastric ulcers induced by in-
domethacin in rats by reduction of oxidative damage (Odaba-
soglu et al., 2004). Also, usnic acid possessed the protective
effects against the damage of human astrocytoma, as the most
common type of glioma (U373 MG) caused by hydrogen per-
oxide (Amo de Paz et al., 2010). Based on the results of this
study, the authors suggested that usnic acid could act as an an-
tioxidant agent in neurodegenerative diseases associated with
oxidative stress, such as Alzheimer’s and Parkinson’s diseases.
Further, in the study of Santos et al. (2004) usnic acid induced
a strong release of NO in peritoneal macrophages, which in-
creased the protection from bacteria and tumors, thereby ex-
hibiting immunostimulatory effect (Santos et al., 2004). In a
study investigating the molecular mechanisms responsible for
the anti-inflammatory activity of usnic acid, it was found that
this substance exhibited a dose-dependent inhibitory effect
on the production of tumor necrosis factor-α, TNF-α (Behera
et al., 2006). In addition, the cardioprotective activity of usnic
acid was demonstrated by Behera et al. (2012). The effect of
usnic acid on wound healing, applying the non-toxic dose in
the experiment with human keratinocytes (HaCaT cells) was
evaluated, as well (Burlando et al., 2009).
3.2.2. Secondary metabolites with depside structure
Atranorin
Atranorin (Figure 3A), one of the most common lichen sec-
ondary metabolites after usnic acid, is the best-studied com-
pound within the lichen family Parmeliaceae (White et al.,
2014). It represents the main substance of the grey cortex
species, such as Cetrelia, Evernia, Pseudoevernia, and Parmelia,
although it was also found in some species of the Parmotrema,
Pseudoevernia, Cladina, Lethariella, Hypotrachyna and Usnea
genus (Gómez-Serranillos et al., 2014; White et al., 2014). Sev-
eral biological activities of atranorin have recently been re-
viewed by Gómez-Serranillos et al. (2014) and also White et al.
(2014). Atranorin exhibited very strong antimicrobial activity
against various bacteria and fungi, shown by Kosanic´ et al.
(2014). Accordingly, Toledo Marante et al. (2003) observed
moderate antibacterial activity of atranorin against S. aureus.
However, atranorin did not possess the antimycotic activity
against filamentous fungi, as shown in the study of Türk et al.
(2006). Cytotoxic activity of atranorin was established in sev-
eral human cancer cell lines (Bacˇkorová et al., 2011; Kosanic´
et al., 2013; Toledo Marante et al., 2003). Antioxidative ac-
tivity of this compound was confirmed in numerous studies
(Jayaprakasha and Rao, 2000; Kosanic´ et al., 2014; Melo et al.,
2011; Papadopoulou et al., 2007; Toledo Marante et al., 2003;
Valencia-Islas et al., 2007) and it could contribute to some
of its pharmacological effects, such as the ability to reduce
skin damage and modulate the wound healing process (Bar-
reto et al., 2013). The study performed by Melo et al. (2011)
demonstrated that atranorin, in addition to the antioxidant,
exhibited prooxidative activity but only at higher concentra-
tions. However, some researchers observed the absence of the
antioxidant activity of atranorin (Thadhani et al., 2011). It was
suggested that atranorin might exhibit the anti-inflammatory
effect by inhibiting the process of leucotriene B4 (LTB4) syn-
thesis (Kumar KC and Müller, 1999a), or analgesic action by
dose-dependent inhibition of cycloxygenase-1 (COX-1) and
partial inhibition of COX-2 (Bugni et al., 2009).
Diffractaic acid
Diffractaic acid (Figure 3B) is, apart from several species of the
genus Usnea, isolated from the species Parmelia tinctorum and
Protousnea magellanica. In up-to-now performed investigations,
this compound was shown to possess antioxidant, gastro-
protective, immunostimulatory, antitumor, anti-inflammatory
and antimicrobial activities (Gómez-Serranillos et al., 2014;
White et al., 2014). In specific, Bayir et al. (2006) confirmed
that different doses of diffractaic acid induced gastroprotec-
tive effects mediated by an antioxidant defense against tis-
sue impairments caused by oxidative stress in indomethacin-
induced gastric lesions in the rat. Odabasoglu et al. (2012)
demonstrated that diffractaic acid, dissolved in olive oil, after
oral administration in rabbits, caused proapoptotic effects in
the tissue surrounding the titanium implants, indicating the
possible mechanism involved in the protection of the tumor
development in various tissues, as a consequence of chemi-
cally induced apoptosis. Besides, Santos et al. (2004) noticed
a strong influence of diffractaic acid on the release of NO in
mouse macrophages, contributing to the immunostimulatory
effect. Diffractaic acid also showed cytotoxic activity against
two cell lines of melanoma (UACC-62 and B16-F10) (Brandão
et al., 2013). In addition, Brisdelli et al. (2013) showed that this
compound possessed good antiproliferative activity against
human colon carcinoma (HCT-116), breast adenocarcinoma
(MCF-7), and cervix carcinoma (HeLa). The antiproliferative
activity of diffractaic acid was also demonstrated on human
keratinocytes, indicating the potential use of this compound
against psoriasis (Kumar KC and Müller, 1999b). The anti-
inflammatory activity of diffractaic acid was evaluated, as
well (Kumar KC and Müller, 1999b). In addition, the study of
Honda et al. (2010) revealed that diffractaic acid, among the
examined metabolites of lichens, possessed the best antimicro-
bial effect against M. tuberculosis.
Barbatic acid
Barbatic acid (Figure 3C), another member of the depsides
family, except in some species of genus Usnea, was also found
in the lichens Cladia aggregates and Heterodea muellers (Molnár
and Farkas, 2010; Shrestha and St. Clair, 2013). Barbatic acid
has been shown to inhibit the growth of S. aureus (Martins
et al., 2010). Yamamoto et al. (1995) identified barbatic acid as
one of the components of lichen U. longissima, which, among
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Fig. 5. Chemical structure of other metabolites of the Usnea lichens: methyl-β-orsenillate (A), longissiminone A (B) and hirtusneanoside (C)
others, mainly contributed to the inhibitory activity against
tumors caused by Epstein Barr virus.
Chloroatranorin
Besides some species of the genus Usnea, chloroatranorin (Fig-
ure 3D) can also be found in the genus Parmotrema, Pseude-
vernia and Lathariella (Gómez-Serranillos et al., 2014; White
et al., 2014). In the available literature data, the antimicro-
bial activity of chloroatranorin against various bacteria and
fungi was confirmed (Türk et al., 2006). Also, in the study
of antioxidant properties of six lichen secondary metabolites,
chloroatranorin showed the best ability to scavenge free rad-
icals (Valencia-Islas et al., 2007). In this regard, the study of
Toledo Marante et al. (2003) confirmed that chloroatranorin
induced the dose-dependent LPO decrease and inhibited the
proliferation of monocytic leukemia cell lines (U937 and HL-
60). Regarding the chloroatranorin analgesic effects, it was
shown this activity was the consequence of partial inhibition
of COX-2 (Bugni et al., 2009).
Evernic acid
In the previously performed research, evernic acid (Figure
3E) was isolated from the lichen E. prunastri and U. longissima
(White et al., 2014). Evernic acid exhibited very strong antimi-
crobial activity against various bacteria and fungi (Kosanic´
et al., 2013). However, Kokubun et al. (2007) performed an in-
vestigation of antimicrobial activity of this compound against
several resistant strains of S. aureus, revealing that it was active
only against one strain. In addition, its antioxidant activity
was evaluated (Kosanic´ et al., 2013). Antitumor activity of ev-
ernic acid was established against Epstein Barr virus tumors
(Yamamoto et al., 1995), malignant mesothelioma (MM98), vul-
var cancer cell lines (A431), keratinocyte (HaCaT) (Burlando
et al., 2009), melanoma (FemX) and human colon carcinoma
(LS 174) (Kosanic´ et al., 2013).
Lecanoric acid
Lecanoric acid (Figure 3F), found in several species of genus
Usnea as well as in the genus Parmotrema, revealed antioxidant
activity, possibly explained by the existing electron attrac-
tion due to two hydrogen bonds between the 2’-OH and the
1’-COOCH3/COOH groups and the 2-OH and the 1-COO-
groups, as well as due to the presence of the COO- group
conjugated to the aromatic ring (Jayaprakasha and Rao, 2000;
Thadhani et al., 2011; White et al., 2014).
3.2.3. Secondary metabolites with depsidone structure
Salazinic acid
Salazinic acid (Figure 4A) has been found in some lichen
species of Xanthoparmelia, Parmelia, Parmotrema, Rimelia, and
Usnea. For this compound, antimicrobial, antitumor, antiox-
idant, neuroprotective and immunostimulatory activity was
described in two recent review papers (Gómez-Serranillos
et al., 2014; White et al., 2014). Interestingly, salazinic acid was
found to be a potential agent used against Alzheimer’s dis-
ease. Namely, having an impact on the reduction of reactive
oxygen species (ROS) production in U373MG cells (human
astrocytes), it might exhibit the neuroprotective effect through
the antioxidant activity or protection against oxidative stress
in astrocytes (Amo de Paz et al., 2010). Santos et al. (2004)
showed an immunostimulatory effect of salazinic acid. This
compound exhibited a strong antioxidant activity (Manojlovic´
et al., 2012; Valencia-Islas et al., 2007). Antimicrobial activity
was evaluated against various bacteria (Candan et al., 2007;
Manojlovic´ et al., 2012; Sultana and Afolayan, 2011) and fungi
(Candan et al., 2007; Manojlovic´ et al., 2012). The cytotoxic
activity of this compound was confirmed against cell lines of
melanoma (FemX) and colon cancer (LS174) (Manojlovic´ et al.,
2012). In addition, Burlando et al. (2009) observed moderate
wound healing effect of non-toxic dose of this compound in
human keratinocytes (HaCaT cells).
Stictic acid
Stictic acid (Figure 4B) is β-orcinol depsidone, found in lichens
U. articulata, Xanthoparmelia conspers, X. camtschadalis, and Ypo-
trachyna revolute (Gómez-Serranillos et al., 2014; White et al.,
2014). Several biological activities of stictic acid were es-
tablished, as outlined by White et al. (2014). For instance,
stictic acid was found to possess protective properties in hu-
man astrocytes-U373MG by reducing the production of ROS,
thereby causing a neuroprotective effect through antioxidant
activity (Amo de Paz et al., 2010). Also, significant antioxida-
tive properties of stictic acid were observed (Papadopoulou
et al., 2007)), but in the investigation performed by Lohézic-
Le Dévéhat et al. (2007) this compound did not exhibit the
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antioxidant activity, which was explained by molecular con-
formation that could affect the ability to "capture" free radicals,
especially DPPH.
Fumaroprotocetric acid
Fumaroprotocetric acid (Figure 4C) is the constituent of Clado-
nia verticillaris, C. rangiferina and U. articulata (White et al.,
2014). The performed research about the biological activities
of this depsidone was summarized in a recent study (White
et al., 2014). Thereby, a strong antioxidant, antimicrobial and
antitumor activities against human melanoma cells (FemX)
and colon carcinoma (LS174) were established (Kosanic´ et al.,
2014; Lohézic-Le Dévéhat et al., 2007). Also, as demonstrated
by Santos et al. (2004) fumaroprotocetric acid exhibited the
immunostimulatory effect by stimulating an increase of NO
release in macrophages, the cells with an important role in the
defense mechanisms of the organism.
Lobaric acid
Lobaric acid (Figure 4D) may be found in some species of the
genus Usnea. In previously performed studies, it was isolated
from several Antarctic lichens such as Sterocaulon alpinum and
Cladonia sp. (White et al., 2014). White et al. (2014) listed
several activities of lobaric acid. In particular, this compound
showed antimicrobial activity against G(+) S. aureus and B.
subtilis (Bhattarai et al., 2013). Brisdelli et al. (2013) revealed
the cytotoxic activity of lobaric acid against human cervix
carcinoma (HeLa) and human colon carcinoma (HCT cells)
only at high concentrations. In the same study, no antioxidant
activity was observed in the DPPH test, what was in contrast
to the findings of Brisdelli et al. (2013). Based on different
concentration ranges used in these studies, it was concluded
that the ability of lobaric acid to scavenge DPPH radicals
might be considered dose-dependent.
Norstistic acid
Norstistic acid (Figure 4E) may be found in various species
of genus Usnea, as well as in other lichens, such as T. candida
(Gómez-Serranillos et al., 2014; White et al., 2014). The in-
vestigation of Rankovic´ et al. (2012) revealed that norstistic
acid exhibited antimicrobial activity against various bacte-
ria and fungi. In addition, in the study of lichens secondary
metabolites activity against M. tuberculosis, it was observed
that norstistic acid showed the best activity after diffractaic
acid (Honda et al., 2010). This compound also showed an
antioxidant activity (Lohézic-Le Dévéhat et al., 2007; Rankovic´
et al., 2012). Additionally, norstistic acid demonstrated an-
tiproliferative activity against human melanoma cells (FemX)
and human colon carcinoma (LS174) by inducing the apoptotic
death (Rankovic´ et al., 2012).
Protocetraric acid
Protocetraric acid (Figure 4F) was found, aside the genus Us-
nea in other lichens such as Hypogymnia physodes and Parmelia
caperata (Shrestha and St. Clair, 2013; White et al., 2014). Pro-
tocetraric acid exhibited strong antimicrobial activity against
various bacteria and fungi. In addition, strong antitumor ac-
tivity against FemX cells and human colon carcinoma (LS174),
was observed, with the strong antioxidant activity, as well
(Manojlovic´ et al., 2012). Protocetraric acid increased the re-
lease of NO and H2O2 in macrophages inducing an immunos-
timulatory effect (Lohézic-Le Dévéhat et al., 2007; Santos et al.,
2004).
Other depsidone compounds
Depisdone compound - psoromic acid (Figure 4G), isolated
from Usnea species showed strong antioxidant activity, pos-
sessing the ability to scavenge free radicals (Behera et al., 2012).
This compound exhibited cardioprotective activity as well (Be-
hera et al., 2012). Psoromic acid showed the selective cyto-
toxicity to melanoma cells (UACC-62) (Brandão et al., 2013).
For galbinic acid (Figure 4H), another member of the class of
depsidones, antimicrobial activity against B. cereus, B. subtilis,
S. aureus, and E. coli was established. The same study demon-
strated antimicrobial activity of menegazziaic acid (Figure
4I) against the same bacteria, with the exception of S. aureus
(Sultana and Afolayan, 2011).
3.2.4. Other secondary metabolites
Benzoic acid derivative, methyl-β-orcinolcarboxylate or
methyl-β-orsenillate (Figure 5A), was shown to possess strong
antibacterial activity against S. aureus (Toledo Marante et al.,
2003) and strong ability to scavenge NO radicals (Thadhani
et al., 2011). Research by Choudhary et al. (2005) revealed
that the phenol compound, longissiminone A (Figure 5B),
isolated from U. longissima, exhibited an anti-inflammatory
response comparable to aspirin. Deoxyglucoside of dimeric
tetrahydroxanthan- hirtusneanoside (Figure 5C), isolated from
U. hirta leaf, showed antimicrobial activity against G(+)
S.aureus and B.subtilis (Rezanka and Sigler, 2007).
CONCLUSION
A detailed review of the literature regarding chemical compo-
sition and biological properties of the genus Usnea confirmed
lichens belonging to this genus to be a valuable source of
compounds with potential medicinal significance. However,
further investigations should be performed with the aim of
providing evidence of these pharmacological effects in vivo as
a prerequisite for their prospective clinical confirmation.
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